Eliem Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	203	74	98	278
Market Cap Growth	-1.42%	-23.65%	-64.90%	-
Enterprise Value	98	-32	-26	141
PE Ratio	-	-2.12	-2.15	-5.34
PB Ratio	1.90	0.69	0.76	1.66
P/FCF Ratio	-10.49	-3.61	-2.61	-7.70
P/OCF Ratio	-10.49	-3.61	-2.61	-7.70
EV/EBITDA Ratio	2.04	0.92	0.57	-2.98
EV/EBIT Ratio	1.99	0.91	0.57	-2.98
EV/FCF Ratio	3.98	1.55	0.68	-3.92
Debt / Equity Ratio	0.00	0.00	0.00	-
Debt / EBITDA Ratio	-0.02	-0.01	-0.01	-
Debt / FCF Ratio	-0.03	-0.02	-0.01	-
Quick Ratio	35.60	37.70	20.27	22.63
Current Ratio	37.03	38.92	22.04	24.58
Return on Equity (ROE)	-13.30%	-31.40%	-32.30%	-83.30%
Return on Assets (ROA)	-12.90%	-30.40%	-30.80%	-40.30%
Return on Capital (ROIC)	-18.61%	-37.31%	-34.94%	-21.33%
Earnings Yield	-7.17%	-47.17%	-46.40%	-18.73%
FCF Yield	-3.57%	-27.67%	-38.33%	-12.99%
Buyback Yield / Dilution	-4.33%	-2.57%	-114.60%	-460.40%
Total Shareholder Return	-4.33%	-2.57%	-114.60%	-460.40%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).